Higher SARS-COV-2 spike antibody levels are associated with reduced risk of subsequent symptomatic and severe COVID-19. Jin, Yue; Yang, Fei; Rank, Christopher; Letovsky, Stanley; Ramge, Peter and Jochum, Simon from Roche Information Solutions, Roche Diagnostics GmbH, Roche Diagnostics Solutions, and Roche Diagnostics International presented a poster during ISPOR 2024. The objective was to assess the…

Creating a holistic direct to consumer (DTC) and healthcare provider (HCP) marketing strategy from scratch is a demanding task, especially if you don’t have the clinical expertise to precisely identify the consumers or providers you should be targeting. We’re here to give you 5 simple steps to creating a holistic DTC and HCP targeting strategy…

Where are the best digital spaces to find healthcare professionals (HCPs) in 2025? If you picture doctors, nurses and other HCPs buried in online medical journals, or engaging in discussions on specialized platforms like Doximity, you’re probably not wrong… But that’s only part of the story. The thing is that HCPs are just like the…

Unlock the Value of Effective Treatments: Discover how life sciences leaders can optimize patient outcomes and healthcare costs by addressing key questions about treatment adherence, healthcare utilization, and cost reduction.

If you’ve tuned into a podcast lately, chances are you’ve noticed that advertising formats have changed a little bit. Maybe you listened to the host give a heartfelt update about needing new revenue streams to keep the show going. Or maybe you noticed a few more ads than usual – some of which weren’t even…

Gram-negative bacteria. The very name can send shivers down the spines of healthcare professionals. These microorganisms, characterized by their complex cell wall structure, are increasingly developing resistance to even our strongest antibiotics.  If bacterial infections in general are a concern, gram-negative bacteria are particularly challenging – since even minor infections can become life-threatening when they…

Unlock unparalleled commercial success with PurpleLab®’s cutting-edge data analytics and real-world insights.

The healthcare landscape is more complex than ever – and pharmaceutical companies are feeling the pressure. From pre-commercial drug development to post-launch performance, success hinges on a deep understanding of the full patient journey. However, traditional approaches to patient mapping often miss the nuanced factors that shape real-world health outcomes. Enter real-world data (RWD) enriched…

Cancer survival rates have improved dramatically over the past few decades thanks to ongoing advances in therapeutics. As research continues to push the boundaries of medicine, two innovative technologies stand out in the fight against cancer: Antibody-Drug Conjugates (ADCs) and PROteolysis TArgeting Chimeras (PROTACs). These cutting-edge approaches are refining how we treat cancer and opening…

For all the buzz around the Inflation Reduction Act (IRA), opinions on its impact are sharply divided – especially in the life sciences sector. Critics argue that the IRA’s drug pricing provisions, particularly Medicare price negotiation, will stifle innovation by reducing incentives for pharmaceutical companies to invest in research and development.  But these concerns don’t…

Nurse Practitioners (NPs) and Physician Assistants (PAs) are no longer just “support” staff for physicians. These clinicians are now taking on much bigger roles in patient care, including the ability to prescribe medications without physician oversight.  The COVID-19 pandemic accelerated the already growing trend of expanding NPs’ and PAs’ scope of practice. Now, five years…